Masimo (MASI) Competitors

IDEXX Laboratories (NASDAQ:IDXX) and Masimo (NASDAQ:MASI) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, community ranking, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk.

Do insiders and institutionals have more ownership in IDXX or MASI?

87.8% of IDEXX Laboratories shares are held by institutional investors. Comparatively, 86.0% of Masimo shares are held by institutional investors. 2.1% of IDEXX Laboratories shares are held by company insiders. Comparatively, 9.7% of Masimo shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Do analysts recommend IDXX or MASI?

IDEXX Laboratories currently has a consensus target price of $533.75, indicating a potential upside of 27.57%. Masimo has a consensus target price of $194.80, indicating a potential upside of 14.72%. Given IDEXX Laboratories' higher probable upside, research analysts clearly believe IDEXX Laboratories is more favorable than Masimo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.80
Masimo	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83

Does the media prefer IDXX or MASI?

In the previous week, IDEXX Laboratories had 15 more articles in the media than Masimo. MarketBeat recorded 25 mentions for IDEXX Laboratories and 10 mentions for Masimo. IDEXX Laboratories' average media sentiment score of 1.43 beat Masimo's score of 1.28 indicating that IDEXX Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	23 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Masimo	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is IDXX or MASI more profitable?

IDEXX Laboratories has a net margin of 22.78% compared to Masimo's net margin of 3.85%. IDEXX Laboratories' return on equity of 55.82% beat Masimo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	22.78%	55.82%	26.48%
Masimo	3.85%	14.98%	6.95%

Which has higher valuation and earnings, IDXX or MASI?

IDEXX Laboratories has higher revenue and earnings than Masimo. Masimo is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$3.90B	8.70	$887.87M	$10.67	39.21
Masimo	$2.09B	4.37	$81.50M	-$5.70	-29.79

Which has more volatility and risk, IDXX or MASI?

IDEXX Laboratories has a beta of 1.39, meaning that its stock price is 39% more volatile than the S&P 500. Comparatively, Masimo has a beta of 1.04, meaning that its stock price is 4% more volatile than the S&P 500.

Does the MarketBeat Community favor IDXX or MASI?

IDEXX Laboratories received 72 more outperform votes than Masimo when rated by MarketBeat users. Likewise, 71.89% of users gave IDEXX Laboratories an outperform vote while only 63.87% of users gave Masimo an outperform vote.

Company	Underperform	Outperform
IDEXX Laboratories	Outperform Votes 537 71.89%	Underperform Votes 210 28.11%
Masimo	Outperform Votes 465 63.87%	Underperform Votes 263 36.13%

Summary

IDEXX Laboratories beats Masimo on 16 of the 19 factors compared between the two stocks.